Plant ID: NPO454
Plant Latin Name: Helianthus annuus
Taxonomy Genus: Helianthus
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
4232
Plant-of-the-World-Online:
n.a.
Antipsoriatic; Antirheumatic; Diuretic; Expectorant; Febrifuge; Stomachic
Indonesia; India; China; Chile; Thailand; Argentina
DRD1; | |
TSHR; | |
MAOA; | |
AHR; | |
UBE2N; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | UBE2N | Ubiquitin-conjugating enzyme E2 N | P61088 | CHEMBL6089 |
Oxidoreductase | MAOA | Monoamine oxidase A | P21397 | CHEMBL1951 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Small molecule receptor (family A GPCR) | DRD1 | Dopamine D1 receptor | P21728 | CHEMBL2056 |
Transcription Factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.997E-09 | 4.348E-05 | CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 5.341E-09 | 5.815E-05 | CYP19A1, CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 2.351E-07 | 8.031E-04 | AHR, CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.760E-07 | 8.031E-04 | CYP19A1, CYP1A2, CYP2D6 |
MF | GO:0005488; binding | GO:0020037; heme binding | 3.746E-07 | 1.020E-03 | CYP19A1, CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 5.929E-07 | 1.291E-03 | CYP19A1, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 9.160E-07 | 1.662E-03 | CYP19A1, CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 5.059E-06 | 7.021E-03 | CYP1A2, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 5.159E-06 | 7.021E-03 | CYP19A1, CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.083E-05 | 1.387E-02 | CYP1A2, CYP2C19 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 5.026E-05 | 3.919E-02 | CYP19A1, CYP1A2, CYP2C19, CYP2D6, DRD1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 2.682E-08 | 9.386E-07 | MAOA, CYP2D6, CYP1A2, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.994E-05 | 3.489E-04 | CYP2D6, MAOA, CYP2C19 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.737E-04 | 1.520E-03 | MAOA, CYP1A2 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 9.070E-05 | 1.058E-03 | CYP1A2, CYP2C19 |
09160 Human Diseases | 09164 Substance dependence | hsa05030 | Cocaine addiction | 2.613E-04 | 1.829E-03 | MAOA, DRD1 |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 4.889E-04 | 2.445E-03 | MAOA, DRD1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 3.664E-04 | 2.138E-03 | CYP1A2, CYP19A1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.802E-04 | 2.539E-03 | CYP2D6, CYP1A2 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.276E-03 | 7.241E-03 | MAOA, CYP1A2, CYP2C19, CYP19A1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 7.315E-04 | 2.845E-03 | CYP1A2, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04728 | Dopaminergic synapse | 1.796E-03 | 6.285E-03 | MAOA, DRD1 |
09160 Human Diseases | 09164 Substance dependence | hsa05034 | Alcoholism | 3.419E-03 | 9.206E-03 | MAOA, DRD1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 2.498E-03 | 7.285E-03 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Dementia | F01-F07 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cocaine addiction | F14.2 | DRD1; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | DRD1; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | DRD1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Psychotic disorders | F20-F29 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Psychiatric disorder | F01-F99 | DRD1; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | DRD1; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Substance dependence | F10-F19 | DRD1; |
I00-I99: Diseases of the circulatory system | Hypertension | I10-I16 | DRD1; |
O00-O9A: Pregnancy, childbirth and the puerperium | Excessive bleeding following childbirth and spontaneous or elective abortion | O04 | DRD1; |